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Abstract
Background: Carbon dioxide (CO2) therapy refers to the transcutaneous administration of CO2 for therapeutic purposes.
This effect has been explained by an increase in the pressure of O2 in tissues known as the Bohr effect. However, there have
been no reports investigating the oxygen dissociation of haemoglobin (Hb) during transcutaneous application of CO2 in
vivo. In this study, we investigate whether the Bohr effect is caused by transcutaneous application of CO2 in human living
body.
Methods: We used a novel system for transcutaneous application of CO2 using pure CO2 gas, hydrogel, and a plastic
adaptor. The validity of the CO2 hydrogel was confirmed in vitro using a measuring device for transcutaneous CO2
absorption using rat skin. Next, we measured the pH change in the human triceps surae muscle during transcutaneous
application of CO2 using phosphorus-31 magnetic resonance spectroscopy (
31P-MRS) in vivo. In addition, oxy- and deoxy-Hb
concentrations were measured with near-infrared spectroscopy in the human arm with occulted blood flow to investigate
O2 dissociation from Hb caused by transcutaneous application of CO2.
Results: The rat skin experiment showed that CO2 hydrogel enhanced CO2 gas permeation through the rat skin. The
intracellular pH of the triceps surae muscle decreased significantly 10 min. after transcutaneous application of CO2. The NIRS
data show the oxy-Hb concentration decreased significantly 4 min. after CO2 application, and deoxy-Hb concentration
increased significantly 2 min. after CO2 application in the CO2-applied group compared to the control group. Oxy-Hb
concentration significantly decreased while deoxy-Hb concentration significantly increased after transcutaneous CO2
application.
Conclusions: Our novel transcutaneous CO2 application facilitated an O2 dissociation from Hb in the human body, thus
providing evidence of the Bohr effect in vivo.
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Introduction
Carbon dioxide (CO2) therapy refers to the transcutaneous or
subcutaneous administration of CO2 for therapeutic purposes
especially in the treatment of peripheral vascular disorder [1]. One
example of this is the use of spa therapy that emerged as an
important treatment in Europe during the 1800 s and is still in use
in many countries today [2]. Another example is the use of
artificial CO2 enriched water for bathing, which has been
clinically applied to improve ischemic limb symptom [3–5]. In
plastic surgery, subcutaneous injection of CO2 is applied if skin
irregularity and/or adiposity occurs [6,7]. Recently, some reports
showed that the transcutaneous administration of CO2 rich spa
gas improves microcirculation and symptoms in patients who have
intermittent claudication [8,9] and Raynoud’s phenomenon [10].
These therapeutic effects of CO2 are caused by an increase in
blood flow and microcirculation assessed by Laser Doppler [10],
and an increase of tcPO2 in ischemic tissues, which is explained by
the Bohr effect [3,5,8,9,11].
The Bohr effect is represented by a rightward shift of the O2–
Hb dissociation curve with an increase in pCO2 or decrease in pH
[12–15]. It has frequently been studied in physiology. However,
subjects’ blood samples were used in these previous experiments,
and the O2 affinity of Hb measured only in vitro or ex vivo. In
addition, although the Bohr effect has often been referred to as an
explanation for the therapeutic usefulness of CO2 therapies, no
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therapies as well as evidence for the transcutaneous absorption of
CO2. In addition, to the best of our knowledge, there have been no
reports that have investigated the Bohr effect in vivo.
To produce the effect of CO2 therapy, an adequate amount of
CO2 needs to be delivered to local tissues without difficulty and
invasion. Previously, only three methods of CO2 therapy have
been reported that have been able to accomplish this. The first
method requires bathing in CO2-enriched water such as in a
carbonated spa [2], or artificially carbonated water prepared by
the chemical reaction of succinic acid and sodium bicarbonate
[3,4], or by blowing micro-bubbles into the water through a CO2
gas-permeable membrane [5,16–19]. However, the CO2 concen-
tration of saturated CO2-enriched water is only 0.1% [16–18] and
there is no evidence of CO2 absorption into the human body. The
second method is direct subcutaneous CO2 injection [6,7]. Even
though direct subcutaneous CO2 injection can deliver pure CO2
into local tissues, this method is invasive, involves an infection risk,
and is difficult to use over a large area of the body.
The third method is the transctaneous administration of CO2
natural spa gas [8–10]. Previous reports have outlined this method
of transctaneous administration of CO2 natural spa gas into the
whole limb as follows: The subjects take a bath, humidify their skin
and then CO2 gas is administered transcutaneously by covering
the subject’s body with a large bag. This method administrates an
adequate CO2 concentration, however, it is difficult to obtain CO2
natural spa gas, and a large space is needed to set up the bath.
To solve these problems, we designed a novel transcutaneous
CO2 application system using 100% CO2 gas, a transcutaneous
CO2 absorption-enhancing hydrogel (CO2 hydrogel) and a CO2
adaptor that seals the body surface and traps the gas inside (Fig. 1,
A and B). In this system, the CO2 hydrogel is applied to the skin to
allow CO2 to dissolve and penetrate into the local tissue, which
humidifies the skin without bathing, thereby forming a passage for
CO2 to reach the local tissues. This system allows for the easy
application of CO2 to any site of the body. In addition, the system
provides for simple sterilization and is not invasive.
In this study, we investigated whether our transcutaneous CO2
application system caused CO2 absorption into local tissues and
the Bohr effect in the human body, by real time and non-invasive
measurement of changes in pH and oxygenated and deoxygen-
ated-hemoglobin volume.
Methods
Novel system for transcutaneous CO2 application
A set of measuring devices for transcutaneous CO2 absorption,
a plastic CO2 adaptor and transcutaneous CO2 absorption-
accelerating hydrogel, (Formulation: carbomer (0.65%), glycerin
(5.00%), sodium hydroxide (0.18%), sodium alginate (0.15%),
sodium dihydrogen phosphate (0.15%), methylparaben (0.10%),
and deionized water (balance)) were obtained from NeoChemir
Inc., Kobe, Japan (International patent publication number:
WO2004/002393). Pure CO2 gas was purchased from Kobe
Sanso Inc., Kobe, Japan. The actual application to humans is
shown in Figures 1A and 1B. When we applied CO2 transcuta-
neously using this system, sweating and redness of the skin were
noted. In addition, the blood flow to the fingers increased, as
shown by a Laser Doppler study (Data not shown).
Validation of transcutaneous CO2 absorption
accelerating hydrogel using a measuring device for
transcutaneous CO2 absorption
Subjects: Six Sprague–Dawley rats were purchased (CLEA Japan,
Tokyo, Japan). The animal experiment plan was reviewed and
approved by the Animal Research Committee of Kobe University
Graduate School of Medicine. The approval ID is P00220.
A set of measuring devices for transcutaneous CO2 absorption
consisting of (1) a container filled with CO2 absorbing solution
(600 mL of pure water) with a pH meter (D52: HORIBA, Kyoto,
Japan) and a magnetic stirrer and (2) an airtight CO2 gas chamber,
with a 5-cm diameter hole covered by a skin specimen positioned
at the bottom of the chamber, was used to observe the
permeability of CO2 gas thorough the rat skin specimen covered
Figure 1. Rationale of the experimental outline. (A) The application of our novel system for transcutaneous application of CO2 (For the upper
limb). (B) The application of our novel system for transcutaneous application of CO2 (For the lower limb).
doi:10.1371/journal.pone.0024137.g001
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solution absorbs CO2 gas through the skin specimen, and the pH
of the solution decreases depending on the volume of the absorbed
CO2 (H2O + CO2 R H
+ + HCO3
2). The skin from depilated
Sprague–Dawley rats was harvested in 10610-cm sections.
Immediately after harvesting, a skin specimen was positioned
over the hole of the chamber, in contact with the CO2-absorbing
solution, the depilated surface facing upwards. CO2 hydrogel
(0.5 g) was applied to the skin specimen in the Gel (+) groups but
not in the Gel (2) groups, and the chamber was filled with pure
CO2 gas. After filling, the pH of the solution was measured in 30-s
intervals for 15 min. by a pH meter.
Measurement of intramuscular pH in vivo using
phosphorus-31 magnetic resonance spectroscopy (
31P-
MRS) during transcutaneous application of CO2 in vivo
Subject: Five healthy male volunteers with no history of
respiratory or vascular disease participated in this study. Subjects
were 23–38 years old (average: 33.066.6). This study was
approved and permitted by the Ethical Committee of Kobe
University Graduate School of Medicine and informed consent
was obtained by written from all subjects before the start of the
study. The approval ID is 997.
31P-MRS: The intramuscular pH was measured in the triceps
surae muscle. All MR studies were performed with a 1.5-T
superconducting imaging system (Gyroscan NT-Intera; Philips
Medical Systems, Best, The Netherlands) and a surface coil. CO2
hydrogel was applied to the subject’s lower leg. A plastic CO2
adaptor was then attached to the subject’s lower leg, and the
surface coil was positioned over the adaptor. After measurement
preparations, pure CO2 gas was flowed into the adaptor. Data
were collected before infusion of CO2 and every 5 min. after
infusion. Quantification of the
31P-MRS metabolite data was
reported before [20], and pHi was determined from the chemical
shift of Pi with respect to PCr.
Measurement of oxygenated and deoxygenated Hb
concentration during transcutaneous application of CO2
in vivo
Subjects: Seven healthy male volunteers with no history of
respiratory or vascular disease participated in this study. Subjects
were 27–40 years of age (average: 32.064.6). This study was
approved and permitted by the Ethical Committee of Kobe
University Graduate School of Medicine and informed consent
was obtained by written from all subjects before the start of the
study. The approval ID is 619.
A near-infrared spectroscopy (NIRS), (NIRO-200 with multi-
fiber adaptor: Hamamatsu Photonics. K. K. Hamamatsu, Japan),
was used for Hb concentration measurement. Changes in
oxygenated and deoxygenated Hb concentrations were measured
using 3 channels by focusing on the differences in absorption of
light at 775, 810, and 850 nm [21–23]. The recording probe was
attached to the inner side of the subject’s forearm. A pneumatic
tourniquet system (ATS2000, Zimmer patient care division,
Dover, OH) commonly used in orthopaedic surgery was used
for avascularization of the arm.
Each subject entered the environmental chamber, which was
maintained at an ambient temperature of 26uC and relative
humidity of 45%. NIRS probes were attached to the subjects’
forearms. A tourniquet was wound around the upper arms, and
then Hb concentration was measured. After confirming that the
oxy-/deoxy-Hb ratio had stabilized, the tourniquet was inflated to
a pressure of 250 mmHg, a commonly used pressure level in
surgeries to avoid bleeding from the forearm (Figure 3). Eight
minutes after the inflation, CO2 hydrogel was applied to the
subject’s forearm, and the entire arm was enclosed by a CO2
adaptor. Ten minutes after the inflation, pure CO2 gas or air
(control) was allowed to flow into the adaptor. The relative
concentrations of the oxy- and deoxy-Hb were measured at 2-s
intervals using NIRS. The duration of tourniquet inflation was
limited to a maximum of 20 min to avoid ischemic damage to
subjects’ tissues.
Statistical analysis
Paired t-tests were used to compare all the variables in the
control and CO2 groups. All values were analysed with
measurement analysis of variance (ANOVA), followed by analysis
of simple main effects. All data are presented as mean 6 S.E.M.
P,0.05 was considered statistically significant.
Figure 2. Measuring device to validate CO2 hydrogel in vitro
using rat skin.
doi:10.1371/journal.pone.0024137.g002
Figure 3. Novel system for transcutaneous CO2 application in
the forearm with NIRS probe.
doi:10.1371/journal.pone.0024137.g003
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Validation of transcutaneous CO2 absorption
accelerating hydrogel using a measuring device for
transcutaneous CO2 absorption
Before we used this system in humans, the validity of the CO2
hydrogel was confirmed in vitro using a measuring device for
transcutaneous CO2 absorption (Figure 2). Four groups of rat skin
specimens with or without CO2 hydrogel that had been filled with
CO2 gas or air were used in the experiment. The CO2-absorbing
solution receives CO2 gas through the skin specimen, and the pH
of the solution decreases, depending on the volume of the
absorbed CO2. The pH of the solution decreased time-
dependently in the CO2 (+) groups, and the pH values were
significantly lower in the CO2 (+) Gel (+) group compared to the
CO2 (+) Gel (2) group after 3.5 min (Figure 4). These results
showed that CO2 hydrogel actually enhanced CO2 gas perme-
ation through the rat skin.
Measurement of intramuscular pH in vivo using
31P-MRS
during transcutaneous application of CO2 in vivo
Next, to test this system in the human body, we measured the
pH change in the muscle during transcutaneous application of
CO2. We used phosphorus-31 magnetic resonance spectroscopy
(
31P-MRS) to measure the intracellular acid–base status in the
subject’s triceps surae muscle [20]. The room temperature was
25uC. CO2 hydrogel was first applied to the subject’s lower leg,
and the CO2 adaptor was attached to seal the lower leg; then the
surface coil was applied over the adaptor adhering it to the calf.
After preparing the subject for measurement, pure CO2 was
infused into the adaptor. The measurements were performed
before CO2 infusion and every 5 min. after infusion. The
intracellular pH of the triceps surae muscle decreased significantly
10 min. after transcutaneous application of CO2 (Figure 5). The
results showed that the intramuscular pH decreased by transcu-
taneous application of CO2 using this system in vivo. Although the
pH change was expected to be buffered by body fluid and active
blood flow, buffering was not enough to prevent the pH change.
From these results, we confirmed that our novel system allowed
transcutaneous penetration of CO2 in vivo.
Measurement of oxygenated and deoxygenated Hb
concentration during transcutaneous application of CO2
in vivo
The oxy- and deoxy-Hb concentrations at all time points during
the experiment are shown in Figure 6A. The oxy-Hb concentra-
tion decreased and the deoxy-Hb concentration increased after
halting the blood flow (resting O2 consumption). The relative
concentrations of oxy- and deoxy-Hb changed gradually, almost
reaching a maximum after 8 min. Both the decrease in oxy-Hb
and the increase in deoxy-Hb were greater in the CO2-applied
arms than in the control arms.
Oxy- and deoxy-Hb concentrations at 8 min. after inflation
were assigned to be the control values. The mean values of 5
Figure 4. pH changes in CO2-absorbing solution during transcutaneous CO2 application through the rat skin with or without the
CO2 hydrogel. The graph shows pH changes during CO2 application with or without the CO2 hydrogel. (n=6). Graph data are expressed as means
6 S.E.M.
doi:10.1371/journal.pone.0024137.g004
Figure 5. Intramuscular pH changes in the triceps surae muscle
during transcutaneous application of CO2 using
31P-MRS. The
graph shows that pH decreases during the accumulation of CO2.( n=5 )
Graph data are expressed as means 6 S.E.M.
doi:10.1371/journal.pone.0024137.g005
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Figure 6B and Table. 1. The data show that the oxy-Hb
concentration decreased significantly 4 min. after CO2 application
(The relative changes of the oxy-Hb concentrations were
233.4623.9% in the CO2 applied group and 211.868.0% in
the air applied (control) group), and that deoxy-Hb concentra-
tion increased significantly 2 min. after CO2 application in the
CO2-applied group compared to the control group (The relative
changes of the deoxy-Hb concentrations were 21.963.6% in the
CO2 applied group and 9.161.6% in the control group). Thus, it
was confirmed that transcutaneous CO2 application facilitates a
decrease in oxy-Hb and an increase in deoxy-Hb in the human
body, providing evidence of O2 dissociation of Hb resulting from
transcutaneous application of CO2 in vivo.
Figure 6. Measurement of oxygenated and deoxygenated Hb concentration during transcutaneous application of CO2 using NIRS.
(A) Continuous measurement of oxy and deoxy-Hb concentrations using NIRS with pooling blood by a pneumatic tourniquet. The bold lines
demonstrate the CO2 group data. All data show the changes in Hb concentrations from the starting point to the end point of measurement (n=7).
Data show the decrease in oxy-Hb and the increase in deoxy-Hb after pooling blood, followed by the greater decrease in oxy-Hb and greater increase
in deoxy-Hb in CO2 group after transcutaneous CO2 application. (B) Relative changes in amounts of oxy/deoxy-Hb (the values 8 min. after blood
pooling started were set as standards). Graph data are expressed as mean 6 S.E.M. The averages and significance checks were calculated based on
measurements of the 7 subjects. Statistical significance at P,0.05 is denoted by *, and P,0.01 is denoted by **. The graph shows a significant
decrease in oxy-Hb and increase in deoxy-Hb in the CO2 group.
doi:10.1371/journal.pone.0024137.g006
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In this study, we showed that our transcutaneous CO2 system
could cause the absorption of CO2, and the Bohr effect in the
human body. A number of studies into the physiological effects of
CO2 therapy, especially CO2-enriched water bathing [3–5,16–19]
and CO2 natural spa gas therapy [8–10] have been published. The
effect of CO2 therapy for peripheral vascular disorder has been
explained by the vasodilation effect by CO2
1,11, and the Bohr
effect [3,5,8–11]. For example, Hartmann et al demonstrated an
increase in tissue oxygen pressure which was caused by CO2-
enriched water bathing, and they concluded this increase was
caused by the Bohr effect [3]. However, they showed no direct
evidence for the Bohr effect in their study. To the best of our
knowledge, there have been no reports that have investigated the
Bohr effect in vivo.
The issue for successful investigation of the Bohr effect in vivo is
that the O2 dissociation from Hb needs to be measured in an in vivo
and real-time manner without taking blood samples. A study by
Jo ¨bsis demonstrated the feasibility of using near-infrared spectros-
copy(NIRS)toassesstheadequacyofO2 provisionandutilization in
living tissues [21]. NIRS can track changes in tissue oxy- and deoxy-
Hb concentrations in a non-destructive, continuous, and real-time
manner; thus, NIRS can be used to assess dynamic changes of the
tissue oxy- and deoxy-Hb concentrations [22,23]. In the present
study, therefore, NIRS was used to confirm whether transcutaneous
CO2 application actually causes O2 dissociation from the oxy-Hb,
which is a characteristic phenomenon of the Bohr effect.
Another issue to be solved is that the blood flow flushes away
CO2-absorbed erythrocytes in vivo. In our preliminary experi-
ments, no changes were observed in oxy- and deoxy-Hb
concentrations during transcutaneous CO2 application to the
arm (data not shown). We hypothesized that this resulted from an
active blood flow that caused an outflow of the deoxy-Hb enriched
erythrocytes, which were then deoxygenated by the transcuta-
neously absorbed CO2, as well as by an inflow of the oxy-Hb
enriched normal erythrocytes. Therefore, we employed a
pneumatic tourniquet (commonly used in a number of surgeries)
[24,25] to halt the blood flow and keep the erythrocytes in the arm
during the transcutaneous CO2 application. In addition, the
pneumatic tourniquet reduced the problems inherent in measuring
the O2 dissociation from the Hb, for example, by an increase in
local tissue temperature caused by a hypercapnia-induced increase
in blood flow. Thus, we believe this study can be regarded as the
first to provide real evidence of the Bohr effect in the human body.
One potential flaw in this study is that NIRS measures not only
Hb but also myoglobin [26,27]. The O2 dissociation curve of
myoglobin is a rectangular hyperbola, and myoglobin releases
oxygen at a very low pO2 [27], as P50 of myoglobin is 2.03 mmHg
at 35uC [28]. In a previous report, tissue pO2 was shown to be
about 25–45 mmHg with blood pooling by applying a pneumatic
tourniquet for 10–20 min [24,25]. In addition, the relationship of
myoglobin P50 with pH is linear [28]. In contrast, the relationship
of Hb P50 with pH is exponential—the well-known Bohr
coefficient [15,29,30]. Therefore, the contamination of myoglobin
in NIRS measurement is expected to have only a minimal
influence on the data.
CO2 therapy has a clinical effect in the treatment of ischemic
legs and Raynoud’s phenomenon. The effect is caused by the
improvement of microcirculation, increasing in tcPO2, and
causing the Bohr effect, which we report here. Our experimental
results also show scientific evidence that our transcutaneous CO2
application can cause an ‘‘Artificial Bohr effect.’’ This artificial
Bohr effect might be a potential new therapy for disorders in
which a high quantity of O2 in local tissues is required for
treatment as well as in the peripheral vascular disorder.
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Table 1. Calculated data showing relative changes in relative amounts of oxy/deoxy-Hb (values 8 min. after blood pooling started
were set as standards).
Time 1 min 2 min 3 min 4 min 5 min 6 min 7 min 8 min 9 min 10 min
Oxy - Hb Control±S.E.M. -0.9% -6.3% -8.8% -11.8% -10.7% -12.5% -14.8% -15.8% -18.3% -18.5%
62.7% 62.2% 62.0% 63.3% 64.1% 63.9% 64.9% 64.2% 65.0% 64.7%
CO2±S.E.M. -26.9% -21.3% -26.4% -33.4% -33.6% -41.2% -43.0% -52.4% -58.0% -64.2%
610.4% 65.2% 610.3% 69.7% 66.8% 68.6% 67.2% 610.9% 612.5% 615.0%
P Value 0.0169 0.1678 0.104 0.0466 0.0351 0.0086 0.0099 0.0009 0.0003 0
Deoxy - Hb Control±S.E.M. 7.3% 9.1% 11.1% 12.7% 13.6% 15.2% 16.6% 17.7% 20.3% 21.4%
61.5% 61.4% 61.5% 61.5% 61.7% 61.7% 61.8% 61.5% 62.0% 62.3%
CO2±S.E.M. 16.3% 21.9% 26.3% 30.0% 32.4% 34.7% 39.1% 42.2% 46.0% 50.6%
63.8% 63.6% 64.1% 64.3% 64.6% 64.8% 65.4% 66.1% 66.8% 67.7%
P Value 0.1088 0.0223 0.0072 0.0023 0.0009 0.0006 0.0001 0 0 0
The data are expressed as mean 6 S.E.M. The averages and significance levels were calculated based on the measurements of the 7 subjects. Statistical significance at
P,0.05 is denoted by * and P,0.01 is denoted by **.
doi:10.1371/journal.pone.0024137.t001
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